Minerba L - Search Results

1

Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.

Massidda B, Atzori F, Scanu A, Contu A, Farris A, Catino AM, Palmeri S, Minerba L, Ionta MT. Massidda B, et al. Among authors: minerba l. Oncology. 2007;72(1-2):17-26. doi: 10.1159/000111084. Epub 2007 Nov 12. Oncology. 2007. PMID: 17998786 Clinical Trial.

2

[Mortality among residents of a region with high environmental risk].

Minerba L, Scarpa B, Contu A. Minerba L, et al. Ann Ig. 2001 Jul-Aug;13(4):339-50. Ann Ig. 2001. PMID: 11590869 Italian. No abstract available.

3

[Risk perception among residents in a region with high environmental risk].

Minerba L, Vollono C, Contu A. Minerba L, et al. Ann Ig. 2001 Sep-Oct;13(5):463-73. Ann Ig. 2001. PMID: 11760421 Italian. No abstract available.

4

Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (<pCR) after primary chemotherapy.

Ionta MT, Atzori F, Deidda MC, Pusceddu V, Palmeri S, Frau B, Murgia M, Barca M, Minerba L, Massidda B. Ionta MT, et al. Among authors: minerba l. Oncologist. 2009 Nov;14(11):1051-60. doi: 10.1634/theoncologist.2009-0077. Epub 2009 Nov 6. Oncologist. 2009. PMID: 19897535 Free article.

5

Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer.

Piras F, Ionta MT, Lai S, Perra MT, Atzori F, Minerba L, Pusceddu V, Maxia C, Murtas D, Demurtas P, Massidda B, Sirigu P. Piras F, et al. Among authors: minerba l. Eur J Histochem. 2011 Nov 14;55(4):e39. doi: 10.4081/ejh.2011.e39. Eur J Histochem. 2011. PMID: 22297445 Free PMC article.

6

Long-term maintenance of prognostic value of survivin and its relationship with p53 in T4 breast cancer patients.

Ionta MT, Perra MT, Atzori F, Maxia C, Pusceddu V, Demurtas P, Deidda MC, Piras F, Frau B, Murtas D, Minerba L, Massidda B, Sirigu P. Ionta MT, et al. Among authors: minerba l. Exp Ther Med. 2010 Jan;1(1):59-64. doi: 10.3892/etm_00000010. Epub 2010 Jan 1. Exp Ther Med. 2010. PMID: 23136593 Free PMC article.

7

Combinations of apoptosis and cell-cycle control biomarkers predict the outcome of human melanoma.

Piras F, Perra MT, Murtas D, Minerba L, Floris C, Maxia C, Demurtas P, Ugalde J, Ribatti D, Sirigu P. Piras F, et al. Among authors: minerba l. Oncol Rep. 2008 Aug;20(2):271-7. Oncol Rep. 2008. PMID: 18636186

8

The stem cell marker nestin predicts poor prognosis in human melanoma.

Piras F, Perra MT, Murtas D, Minerba L, Floris C, Maxia C, Demurtas P, Ugalde J, Ribatti D, Sirigu P. Piras F, et al. Among authors: minerba l. Oncol Rep. 2010 Jan;23(1):17-24. Oncol Rep. 2010. PMID: 19956860

9

Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.

Murtas D, Piras F, Minerba L, Ugalde J, Floris C, Maxia C, Demurtas P, Perra MT, Sirigu P. Murtas D, et al. Among authors: minerba l. Oncol Rep. 2010 Feb;23(2):329-35. Oncol Rep. 2010. PMID: 20043092

10

Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma.

Murtas D, Piras F, Minerba L, Ugalde J, Piga M, Maxia C, Perra MT, Sirigu P. Murtas D, et al. Among authors: minerba l. Oncol Lett. 2010 Jul;1(4):633-639. doi: 10.3892/ol_00000112. Epub 2010 Jul 1. Oncol Lett. 2010. PMID: 22966356 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters